Cytokines claimed spotlight due to COVID-19. Now, Merck will work with Synthekine to understand their role in autoimmune disorders

The world got a little more steeped in cytokine knowledge because of the small protein's role in COVID-19, and, now, Merck will study how cytokines work in autoimmune diseases through a $525 million biobucks deal with Synthekine.